Replacement of renal function in uremic animals with a tissue- engineered kidney

Nature Biotechnology

Volumn 17, Issue 5, 1999, Pages 451-455

  Humes, H David ^a   Buffington, Deborah A ^a   MacKay, Sherrill M ^a   Funke, Angela J ^a   Weitzel, William F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cell therapy; Kidney; Tissue engineering; Tubule cells

Indexed keywords

CALCITRIOL; CREATININE; ELECTROLYTE; GLUCOSE; NITROGEN; UREA;

AMMONIA FORMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL KIDNEY; BIOMEDICAL ENGINEERING; CELL ADHESION; CELL TRANSPORT; CELL VIABILITY; CONTROLLED STUDY; DEVICE; DOG; GLOMERULUS; GLUTATHIONE METABOLISM; HEMODIALYSIS; HEMOFILTRATION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; NONHUMAN; PRIORITY JOURNAL; ULTRAFILTRATION; UREMIA;

ANIMALS; BIOTECHNOLOGY; CELL TRANSPLANTATION; DOGS; HEMOFILTRATION; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; KIDNEY TUBULES; KIDNEY, ARTIFICIAL; MEMBRANES, ARTIFICIAL; SWINE;

ANIMALIA; CANIS FAMILIARIS; GLOMERULUS; SUIDAE;

EID: 0032963942     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/8626     Document Type: Article

References (28)

1. Gage, F.H. Cell therapy. Nature 392, 518-524 (1998).
2. Langer, R. & Vacanti, J.P. Tissue engineering. Science 260, 920-926 (1993).
3. Watanabe, F.D. et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann. Surg. 225, 484-491 (1997).
4. Maki, T. et al. Treatment of diabetes by xenogeneic islets without immunosuppression. Use of a vascularized bioartificial pancreas. Diabetes 45, 342-347 (1996).
5. Humes, H.D., MacKay, S.M., Funke, A.J. & Buffington, D.A. Acute renal failure: growth factors, cell therapy, gene therapy. Proc. Assoc. Am. Physicians 109, 547-557 (1997).
6. Yagi, N. & Paganini E.P. Acute dialysis and continuous renal replacement: the emergence of new technology involving the nephrologist in the intensive care setting. Semin. Nephrol. 17, 306-320 (1997).
7. Mehta, R.L. Therapeutic alternatives to renal replacement for critically ill patients in acute renal failure. Semin. Nephrol. 14, 64-82 (1994).
8. Zarowitz, B.J., Anandan, J.V., Dumler, F., Jayashankar, J. & Levin, N. Continuous arteriovenous hemofiltration of aminoglycoside antibiotics in critically ill patients. J. Clin. Pharm.. 26, 686-689 (1986).
9. Excerpts from United States Renal Data System. Annual Data Report. Am.. J. Kidney Dis. 32(suppl 1), 569-580 (1998).
10. Humes, H.D. Acute renal failure: prevailing challenges and prospects for the future. Kidney Int. 48, S-26-S-32 (1995).
11. Humes, H.D., MacKay, S.M., Funke, A.J. & Buffington D.A. The bioartificial renal tubule assist device to enhance CRRT in acute renal failure. Am. J. Kidney Dis. 30, S28-S31 (1997)
12. MacKay, S.M., Funke, A.J., Buffington, D.A. & Humes, H.D. Tissue engineering of a bioartificial renal tubule. ASAIO J. 44, 179-183 (1998).
13. Humes, H.D., MacKay, S.M., Funke, A.J. & Buffington, D.A. Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kidney Int. (In press).
14. Nikolovski, J., Gulari, E. & Humes, H.D. Design engineering of a bioartificial renal tubule cell therapy device. Cell Transplant. (In press).
15. Bidlack, J.M. & Lockshin, R.A. Evolution of LDH isozymes during programmed cell death. Comp. Biochem. Physiol. 55, 161-166 (1976).
16. Knox, F.G., Merz, J.I., Burnett, J.C. Jr & Haramati, A. Role of hydrostatic and oncotic pressures in renal sodium reabsorption. Circ. Res. 52, 491-500 (1983).
17. Berry, C.A., Ives, H.E. & Rector, F.C. Jr. in The Kidney 5th edn (ed. Brenner, B.M.) 334-370 (W.B. Saunders, Philadelphia, 1996).
18. Pitts, R.F. The renal regulation of acid base balance with special reference to the mechanism for acidifying the urine. I and II. Science 102, 49-51, 81-85 (1945).
19. Schoolwerth, A.C. Regulation of renal ammoniagenesis in metabolic acidosis. Kidney Int. 40, 961-973 (1991).
20. Curthoys, N.P. Role of γ-glutamyltranspeptidase in the renal metabolism of glutathione. Miner. Electrolyte Metab. 9, 236-245 (1983).
21. Lehmann, J. Jr & Gray, R.W. in Renal Endocrinology, (ed. Dunn, M.J.) 114-141 (Williams & Wilkins, Baltimore, MD, 1983).
22. Humes, H.D. in Biomedical Engineering Handbook. (ed. Bronzino, J.) 1807-1824 (CRC, 1995).
23. Humes, H.D. & Cieslinski, D.A. Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis in tissue culture. Exp. Cell Res. 201, 8-15 (1992).
24. Humes, H.D., Krauss, J.C., Cieslinski, D.A. & Funke, A.J. Tubulogenesis from isolated single cells of adult mammalian kidney: clonal analysis with a recombinant retrovirus. Am. J. Physiol. 271, F42-F49 (1996).
25. Timpl, R. et al. Laminin - a glycoprotein from basement membranes. J. Biol. Chem. 254, 9933-9937 (1979).
26. O'Neil J.J. et al. Immunoprotection provided by the bioartificial pancreas in a xenogeneic host. Trans. Proc. 29, 2116-2117 (1997).
27. Pitts, R.F. Renal excretion of acid. Fed. Proc, 7, 418-426 (1948).
28. Cozzi, E. & White, D. The generation of transgenic pigs as potential organ donors for humans. Nat. Med. 1, 965-966 (1995).